My PCR
Create Account
Logo PCR

20 Nov 2023

!!!NEWSFLASH!!! Long-term outcomes of the TAVI low risk trials - from headlines to clinical practice

Facilitators: D. Blackman, B. Prendergast
Discussants: S. Bleiziffer, M. Borger, P. Juni, F. Praz
SHOW MORE

Summary

Join this session to navigate through the long-term outcomes of TAVI low-risk trials (Partner 3, Evolut Low Risk...), to enhance your ability to synthesize and interpret clinical evidence and to learn how to seamlessly integrate these insights into your Heart Team's daily clinical practice.

Learning Objectives

  • To hear more about the recently published long-term outcomes of the TAVI low risk trials
  • To understand how to synthesise and interpret this important clinical evidence
  • To translate this understanding into your Heart Team's daily clinical practice

Presentations available when logged in:

  • The Partner 3 trial: 5 year outcomes
  • The Evolut Low Risk trial: 4 year outcomes
  • Synthesis – What these trials CAN tell us (and what they CANNOT)